丙戊酸在创伤和失血性休克猪模型中诱导促生存转录组改变
该研究纳入6头雌性约克夏猪,建立创伤性脑损伤、多部位创伤和失血性休克(40%总血容量)模型,休克2小时后随机分为生理盐水复苏组或生理盐水+静脉丙戊酸150 mg/kg组(每组3头,共18份样本)。在基线、伤后6小时和伤后第1天采集外周血单核细胞进行RNA测序,差异表达分析采用错误发现率<0.001且p值<0.001。共鉴定628个差异表达RNA转录本,其中412个用于分析,基线时两组无差异,丙戊酸诱导的基因改变在6小时和伤后第1天相似。上调基因与基因表达、细胞发育、细胞生长与增殖及糖皮质激素受体信号相关,下调基因与细胞周期检查点调控、凋亡信号、急性期反应信号和炎症小体通路相关。作者认为这些基因改变可解释丙戊酸治疗动物临床结局更优(包括脑病灶更小和神经功能恢复更好)。
要点
- 猪创伤失血性休克模型中,丙戊酸150 mg/kg静脉给药后上调细胞生存、增殖与分化相关基因,下调细胞死亡与炎症相关基因。
- 差异表达分析共鉴定628个差异表达RNA转录本,其中412个用于分析;基线时两组无差异。
- 丙戊酸诱导的基因改变在伤后6小时和伤后第1天相似。
- 上调基因关联基因表达(p 2.13E-34)、细胞发育(1.19E-33)、细胞生长与增殖(1.25E-30)及糖皮质激素受体信号(8.6E-21)。
- 下调基因关联细胞周期检查点调控(3.64E-22)、凋亡信号(6.54E-21)、急性期反应信号(5.84E-23)及炎症小体通路(1.7E-19)。
适用人群与场景
- 雌性约克夏猪,遭受创伤性脑损伤(控制性皮质撞击)、多部位创伤(肝脾撕裂、肋骨骨折、腹直肌挤压伤)和失血性休克(40%总血容量)。
诊断标准与关键阈值
- 差异表达分析阈值:错误发现率<0.001且p值<0.001。
处置流程与药物剂量
- 失血性休克2小时后随机复苏:生理盐水或生理盐水+丙戊酸150 mg/kg静脉给药(每组3头,共18份样本)。
- 在基线、伤后6小时和伤后第1天采集血样分离外周血单核细胞,提取RNA并测序。
研究设计与关键结果
- 研究类型:动物实验(猪创伤失血性休克模型),样本量6头(每组3头,共18份样本),干预为生理盐水+静脉丙戊酸150 mg/kg vs 生理盐水。
- 共鉴定628个差异表达RNA转录本,其中412个用于分析;基线时两组无差异。
- 丙戊酸诱导的基因改变在伤后6小时和伤后第1天相似。
- 上调基因关联基因表达(p 2.13E-34)、细胞发育(1.19E-33)、细胞生长与增殖(1.25E-30)、糖皮质激素受体信号(8.6E-21)。
- 下调基因关联细胞周期检查点调控(3.64E-22)、凋亡信号(6.54E-21)、急性期反应信号(5.84E-23)、炎症小体通路(1.7E-19)。
证据类型、等级与局限
- 证据类型:动物实验(猪模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,丙戊酸在创伤失血性休克猪模型中诱导的促生存转录组改变可解释丙戊酸治疗动物临床结局更优,包括脑病灶更小和神经功能恢复更好。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Valproic acid (VPA) is a histone deacetylase inhibitor that improves outcomes in large animal models of trauma. However, its protective mechanism of action is not completely understood. We sought to characterize the genetic changes induced by VPA treatment following traumatic injuries.
METHODS: Six female Yorkshire swine were subjected to traumatic brain injury (controlled cortical impact), polytrauma (liver and splenic laceration, rib fracture, rectus crush), and hemorrhagic shock (HS, 40% total blood volume). Following 2 hours of HS, animals were randomized to resuscitation with normal saline (NS) or NS + 150 mg/kg of intravenous VPA (n = 3/cohort, 18 samples total). Blood samples were collected for isolation of peripheral blood mononuclear cells at three distinct time points: baseline, 6 hours following injuries, and on postinjury day 1. RNA was extracted from peripheral blood mononuclear cells and sequenced. Differential expression analysis (false discovery rate < 0.001 and p value <0.001) and gene set enrichment (Panther Gene Ontology and Ingenuity Pathway Analysis) was used to compare VPA to non-VPA-treated animals.
RESULTS: A total of 628 differentially expressed RNA transcripts were identified, 412 of which were used for analysis. There was no difference between treatment groups at baseline. The VPA-induced genetic changes were similar at 6 hours and on postinjury day 1. Upregulated genes were associated with gene expression (p 2.13E-34), cellular development (1.19E-33), cellular growth and proliferation (1.25E-30), and glucocorticoid receptor signaling (8.6E-21). Downregulated genes were associated with cell cycle checkpoint regulation (3.64E-22), apoptosis signaling (6.54E-21), acute phase response signaling (5.84E-23), and the inflammasome pathway (1.7E-19).
CONCLUSION: In injured swine, VPA increases the expression of genes associated with cell survival, proliferation, and differentiation and decreases those associated with cell death and inflammation. These genetic changes could explain the superior clinical outcomes in VPA-treated animals, including smaller brain lesion size and improved neurologic recovery.
参考来源
- Georgoff PE, Nikolian VC, Higgins G, et al. Valproic acid induces prosurvival transcriptomic changes in swine subjected to traumatic injury and hemorrhagic shock. J Trauma Acute Care Surg. 2018. PMID: 29251706. doi:10.1097/TA.0000000000001763
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。